TAYLORE CHANILLO: Open Payments
NPI 1982352530 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,011 in 121 payments from 25 companies in 2025. Trend: 2023 $59 · 2024 $1,418 · 2025 $3,011
Food & beverage: $3,011
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 17 | $549 |
| Novartis Pharmaceuticals Corporation | 28 | $394 |
| Amgen Inc. | 3 | $324 |
| Celgene Corporation | 16 | $238 |
| Janssen Biotech, Inc. | 12 | $220 |
| Axsome Therapeutics, Inc. | 7 | $190 |
| Genentech USA, Inc. | 6 | $161 |
| Vanda Pharmaceuticals Inc. | 3 | $160 |
| Genentech, Inc. | 2 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
Products named: BRIUMVI, KESIMPTA, ZEPOSIA, UPLIZNA, TREMFYA, Ocrevus, PONVORY, Symbravo.
Industry payments across NJ — which companies pay providers there.
